Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Oct 2025 07:00

RNS Number : 1788D
Ashmore Group PLC
14 October 2025
 

Ashmore Group plc 14 October 2025

FIRST QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ended 30 September 2025.

Assets under management

Investment theme

Actual30 June 2025

(US$ billion)

Estimated30 September 2025

(US$ billion)

- External debt

7.4

7.2

- Local currency

14.2

14.4

- Corporate debt

5.2

5.4

- Blended debt

11.7

12.1

Fixed income

38.5

39.1

Equities

7.5

7.8

Alternatives

1.6

1.8

Total

47.6

48.7

 

AuM increased by US$1.1 billion (+2%) over the period, comprising positive investment performance of US$1.4 billion and net outflows of US$0.3 billion.

Net flows continued to improve through both higher subscriptions and a further reduction in redemptions, as investors increasingly recognise the outperformance and relative attractions of emerging markets. There were net inflows in the local currency, equity and alternatives themes, and a net outflow in external debt driven by institutional activity early in the period. Net flows in blended debt and corporate debt were flat. In aggregate, this activity delivered a net inflow to the Group's globally-managed strategies.

Emerging markets delivered strong returns over the three months, with fixed income indices rising by 3% to 5%, and the main equity indices returning around 10%. Ashmore's active management approach continues to generate outperformance for clients across the Group's fixed income and equity strategies.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging markets continue to perform strongly, which, along with Ashmore's alpha delivery for clients, is leading to broad client engagement and increasing momentum across the business. This has led to a further improvement in net flows this quarter. The Group has a consistent strategy for growth and the focus on building greater scale in equities and alternatives is successfully delivering net inflows in these investment themes.

"Given the positive emerging markets backdrop, evident risks to investors' overweight positions in the US, and Ashmore's continued investment outperformance, the Group is well-positioned to capture additional flows as investors increasingly look to shift allocations away from the US including into emerging markets."

Notes

Local currency AuM includes US$7.8 billion of AuM managed in overlay/liquidity strategies (30 June 2025: US$7.9 billion).

 

For further information please contact:

Ashmore Group plc Paul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

Cardew Group Tom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRISLVLIE
Date   Source Headline
19th Aug 20242:55 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSTrading statement
31st May 20244:17 pmRNSHolding(s) in Company
31st May 20243:15 pmRNSDirector/PDMR Shareholding
1st May 20243:01 pmRNSDirectorate Change
1st May 202411:11 amRNSDirector/PDMR Shareholding
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.